Clinical Trial Update: An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial assessing the safety and efficacy of SZC (sodium zirconium cyclosilicate) in pediatric patients with hyperkalemia; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• SZC (sodium zirconium cyclosilicate) (sodium zirconium cyclosilicate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia | Phase 3 | Status: RECRUITING